Brief: Evofem Biosciences Inc Says It May Consider Available Options To Regain Compliance With Nasdaq Bid Price Requirement
27/08/2021 11:12
Aug 27 (Reuters) - Evofem Biosciences Inc EVFM.O :
* EVOFEM BIOSCIENCES INC - MAY, IF APPROPRIATE, CONSIDER
AVAILABLE
OPTIONS TO REGAIN COMPLIANCE WITH NASDAQ BID PRICE REQUIREMENT
Source: [ID:https://bit.ly/3gENXGt]
Further company coverage: EVFM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evofem Biosciences
See all newsBrief: Evofem Biosciences Adds Additional Manufacturing Capacity For Phexx To Support Global Growth Strategy
Brief: HUB Cyber Security Expands Into Women's Health With Zero-Cash Acquisition Of Evofem Notes
Evofem Biosciences Q1 sales edge up on higher pricing
Evofem Biosciences Q3 net sales rise
Brief: Evofem Anticipates Approval Of Merger With Aditxt At Upcoming Stockholder Meeting